These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7992223)

  • 21. [Hypertension in the elderly].
    Reinhart WH
    Schweiz Med Wochenschr; 1996 Aug; 126(34):1442-5. PubMed ID: 8848707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diuretics for cardiovascular prevention in the elderly.
    Hanon O; Seux ML; Lenoir H; Rigaud AS; Girerd X; Forette F
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S15-22. PubMed ID: 15592568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The hypertensive type II diabetic patient treated with captopril in free general practice (Austrian Safety Study). An indications study].
    Stanek B; Basalka E; Seitl K; Fiser I
    Wien Med Wochenschr; 1997; 147(11):267-74. PubMed ID: 9334064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systolic hypertension in the elderly: potential for primary prevention of cardiovascular disease.
    Rich MW
    Aging (Milano); 1998 Apr; 10(2):169. PubMed ID: 9666225
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug treatment of pre-hypertension--pro].
    Schrader J
    Dtsch Med Wochenschr; 2008 Jun; 133(24):1304. PubMed ID: 18528797
    [No Abstract]   [Full Text] [Related]  

  • 26. [The best of arterial hypertension in 1999].
    Milon H
    Arch Mal Coeur Vaiss; 2000 Jan; 93(1 Spec No):9-15. PubMed ID: 10721443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Physical activity as component of cardiovascular disease prevention in elderly people].
    Kałka D; Sobieszczańska M; Marciniak W
    Pol Merkur Lekarski; 2007 Jan; 22(127):48-53. PubMed ID: 17477091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The first report of the Systolic and Pulse Pressure (SYPP) Working Group.
    Black HR; Kuller LH; O'Rourke MF; Weber MA; Alderman MH; Benetos A; Burnett J; Cohn JN; Franklin SS; Mancia G; Safar M; Zanchetti A
    J Hypertens Suppl; 1999 Dec; 17(5):S3-14. PubMed ID: 10706319
    [No Abstract]   [Full Text] [Related]  

  • 29. [Type 2 diabetes and cardiovascular risk: lessons from therapeutic trials].
    Lièvre M
    Rev Prat; 2001 Oct; 51(16):1793-9. PubMed ID: 11795124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacologic interventions in primary prevention: lipid lowering drugs, aspirin, antiobesity drugs, and antihypertensive agents].
    Auer J; Berent R; Weber T; Porodko M; Mayr H; Maurer E; Eber B
    Wien Med Wochenschr; 2001; 151(1-2):13-7. PubMed ID: 11234591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are guidelines effectively guiding antihypertensive therapy?
    Vasan RS; Kannel WB
    Am J Cardiol; 2007 Jul; 100(1):143-4. PubMed ID: 17599457
    [No Abstract]   [Full Text] [Related]  

  • 32. Integrated cardiovascular risk management for the future: lessons learned from the ASCOT trial.
    Volpe M; Tocci G
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):46-53. PubMed ID: 16640173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood pressure and cardiovascular risk reduction--new targets, new challenges.
    Jackson G
    Int J Clin Pract; 2005 Jul; 59(7):743. PubMed ID: 15963195
    [No Abstract]   [Full Text] [Related]  

  • 34. Commentary: The challenge of prevention in China.
    McGhee SM; Hedley AJ
    Int J Epidemiol; 2010 Feb; 39(1):254-5. PubMed ID: 20056766
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiometabolic risk-factor management.
    Ker J
    Cardiovasc J Afr; 2008; 19(4):222-4. PubMed ID: 18776972
    [No Abstract]   [Full Text] [Related]  

  • 37. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.
    Mazzaglia G; Ambrosioni E; Alacqua M; Filippi A; Sessa E; Immordino V; Borghi C; Brignoli O; Caputi AP; Cricelli C; Mantovani LG
    Circulation; 2009 Oct; 120(16):1598-605. PubMed ID: 19805653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Arterial hypertension and hypertensive cardiopathy at the turn of the millenium].
    González-Juanatey JR
    Rev Esp Cardiol; 1999; 52 Suppl 3():1-3. PubMed ID: 10614143
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prevention of cardiovascular diseases. 1998 guidelines of the National Cardiovascular Conference (NCC)].
    Becker HJ; Schwandt P; Held K; Bönner G
    Dtsch Med Wochenschr; 1999 Oct; 124(42):1249-52. PubMed ID: 10572535
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of arterial hypertension in the elderly].
    Girerd X; Hanon O
    Arch Mal Coeur Vaiss; 2000 Nov; 93(11 Suppl):1411-6. PubMed ID: 11190289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.